Inflammatory and Myocardial Biomarker Response Following Pulmonary Vein Isolation: Cryoballoon Versus Balloon-in-Basket Pulsed Field Ablation

肺静脉隔离术后炎症和心肌生物标志物反应:冷冻球囊消融术与球囊篮式脉冲场消融术的比较

阅读:1

Abstract

BACKGROUND: Cryoballoon ablation (CB) is a well-established thermal technique for pulmonary vein isolation (PVI), while balloon-in-basket pulsed field ablation (BiB-PFA) represents a novel non-thermal alternative. Both single-shot systems may trigger systemic inflammation and myocardial injury, yet direct comparisons are lacking. This study aimed to compare inflammatory and myocardial biomarker responses following first-time PVI using CB or BiB-PFA. METHODS: In this prospective, single-center study, 100 patients undergoing PVI for symptomatic paroxysmal or persistent atrial fibrillation (AF) were enrolled (CB: n =  50; BiB-PFA: n =  50). Venous blood samples were collected before and on the morning after ablation to assess leukocytes, C-reactive protein (CRP), platelets, troponin T, creatine kinase (CK), myoglobin, creatinine, and estimated glomerular filtration rate. Baseline characteristics, procedural data, and acute success were analyzed. RESULTS: Patients in the CB group were older (74 vs. 65 years; p =  0.01) and had higher CHA₂DS₂-VAcore (3.0 vs. 2.0; p  =  0.009). Acute PVI was achieved in all cases CB was associated with greater increases in leukocytes (Δ2.5 vs. 1.1 × 10⁹/L; p  =  0.05) and CRP (Δ5.8 vs. 3.4 mg/L; p =  0.02), whereas BiB-PFA showed higher rises in CK (Δ217 vs. 103 U/L; p  =  0.01) and troponin T (Δ1129 vs. 614.5 ng/L; p =  0.01). No significant correlation was found between energy delivery and biomarker changes. CONCLUSION: CB and BiB-PFA elicit distinct systemic responses. CB provoked stronger inflammatory activation, while BiB-PFA caused greater myocardial biomarker release, suggesting energy- and device-specific effects.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。